A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy of Omalizumab in Prevention of Bronchoconstriction Following Environmental Aeroallergen Exposure

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy of Omalizumab in Prevention of Bronchoconstriction Following Environmental Aeroallergen Exposure

Spirometry was performed at baseline and every 10 minutes during the exposure to determine the primary endpoint: area under the curve (AUC) of percent decrease in the forced expiratory volume in 1 second (FEV1) during 1-hour exposure at week 16 for omalizumab versus placebo-treated subjects.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.AB72-AB72
Hauptverfasser: Corren, J, Wood, R.A, Patel, D, Zhu, J, Fish, J.E
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Asthma
Drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Spirometry was performed at baseline and every 10 minutes during the exposure to determine the primary endpoint: area under the curve (AUC) of percent decrease in the forced expiratory volume in 1 second (FEV1) during 1-hour exposure at week 16 for omalizumab versus placebo-treated subjects.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2009.12.282